{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:21:08Z","timestamp":1787610068452,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"35","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.1038\/s41388-026-03917-3","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:06:32Z","timestamp":1784826392000},"page":"3633-3646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["N6-methyladenosine\u2013mediated upregulation of PAICS promotes lung-adenocarcinoma metastasis via the integrin-FAK signaling"],"prefix":"10.1038","volume":"45","author":[{"given":"Mengzhu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-5440","authenticated-orcid":false,"given":"Jianjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-2970","authenticated-orcid":false,"given":"Jian-an","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2528-6909","authenticated-orcid":false,"given":"Zeyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"3917_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41419-017-0063-y","volume":"9","author":"TV Denisenko","year":"2018","unstructured":"Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018;9:117.","journal-title":"Cell Death Dis"},{"key":"3917_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101057","volume":"73","author":"J Liang","year":"2024","unstructured":"Liang J, Bi G, Huang Y, Zhao G, Sui Q, Zhang H, et al. MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma. Drug Resist Updates. 2024;73:101057.","journal-title":"Drug Resist Updates"},{"key":"3917_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102237","volume":"99","author":"L Succony","year":"2021","unstructured":"Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC. Adenocarcinoma spectrum lesions of the lung: detection, pathology and treatment strategies. Cancer Treat Rev. 2021;99:102237.","journal-title":"Cancer Treat Rev"},{"key":"3917_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14.","journal-title":"Mol Cancer"},{"key":"3917_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3917_CR6","doi-asserted-by":"publisher","first-page":"W548","DOI":"10.1093\/nar\/gkz479","volume":"47","author":"Q Liu","year":"2019","unstructured":"Liu Q, Gregory RI. RNAmod: an integrated system for the annotation of mRNA modifications. Nucleic Acids Res. 2019;47:W548\u2013w55.","journal-title":"Nucleic Acids Res"},{"key":"3917_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, When, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74:640\u201350.","journal-title":"Mol Cell"},{"key":"3917_CR8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.7150\/thno.77441","volume":"13","author":"R Sun","year":"2023","unstructured":"Sun R, Yuan L, Jiang Y, Wan Y, Ma X, Yang J, et al. ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer. Theranostics. 2023;13:833\u201348.","journal-title":"Theranostics"},{"key":"3917_CR9","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","volume":"164","author":"J Wang","year":"2023","unstructured":"Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W, et al. N6-methyladenosine-mediated up-regulation of FZD10 regulates liver cancer stem cells\u2019 properties and lenvatinib resistance through WNT\/\u03b2-catenin and hippo signaling pathways. Gastroenterology. 2023;164:990\u20131005.","journal-title":"Gastroenterology"},{"key":"3917_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"3917_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3389\/fbioe.2020.00677","volume":"8","author":"J Acosta","year":"2020","unstructured":"Acosta J, Del Arco J, Del Pozo ML, Herrera-Tapias B, Clemente-Su\u00e1rez VJ, Berenguer J, et al. Hypoxanthine-guanine phosphoribosyltransferase\/adenylate kinase from Zobellia galactanivorans: a bifunctional catalyst for the synthesis of nucleoside-5\u2019-mono-, di- and triphosphates. Front Bioeng Biotechnol. 2020;8:677.","journal-title":"Front Bioeng Biotechnol"},{"key":"3917_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gde.2009.01.002","volume":"19","author":"X Tong","year":"2009","unstructured":"Tong X, Zhao F, Thompson CB. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev. 2009;19:32\u20137.","journal-title":"Curr Opin Genet Dev"},{"key":"3917_CR13","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.1007\/s00253-018-9242-8","volume":"102","author":"J Del Arco","year":"2018","unstructured":"Del Arco J, Fern\u00e1ndez-Lucas J. Purine and pyrimidine salvage pathway in thermophiles: a valuable source of biocatalysts for the industrial production of nucleic acid derivatives. Appl Microbiol Biotechnol. 2018;102:7805\u201320.","journal-title":"Appl Microbiol Biotechnol"},{"key":"3917_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2018.12.064","volume":"692","author":"S Zhou","year":"2019","unstructured":"Zhou S, Yan Y, Chen X, Wang X, Zeng S, Qian L, et al. Roles of highly expressed PAICS in lung adenocarcinoma. Gene. 2019;692:1\u20138.","journal-title":"Gene"},{"key":"3917_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100776","volume":"13","author":"S Agarwal","year":"2020","unstructured":"Agarwal S, Chakravarthi B, Kim HG, Gupta N, Hale K, Balasubramanya SAH, et al. PAICS, a de novo purine biosynthetic enzyme, is overexpressed in pancreatic cancer and is involved in its progression. Transl Oncol. 2020;13:100776.","journal-title":"Transl Oncol"},{"key":"3917_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/pros.23533","volume":"78","author":"B Chakravarthi","year":"2018","unstructured":"Chakravarthi B, Goswami MT, Pathi SS, Dodson M, Chandrashekar DS, Agarwal S, et al. Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer. Prostate. 2018;78:693\u20134.","journal-title":"Prostate"},{"key":"3917_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.neo.2018.07.006","volume":"20","author":"B Chakravarthi","year":"2018","unstructured":"Chakravarthi B, Rodriguez Pena MDC, Agarwal S, Chandrashekar DS, Hodigere Balasubramanya SA, Jabboure FJ, et al. A role for de novo purine metabolic enzyme PAICS in bladder cancer progression. Neoplasia. 2018;20:894\u2013904.","journal-title":"Neoplasia"},{"key":"3917_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-00938-1","volume":"8","author":"L Lang","year":"2022","unstructured":"Lang L, Tao J, Yang C, Li W. Tumor suppressive role of microRNA-4731-5p in breast cancer through reduction of PAICS-induced FAK phosphorylation. Cell Death Discov. 2022;8:154.","journal-title":"Cell Death Discov"},{"key":"3917_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535\u201354.","journal-title":"Lancet"},{"key":"3917_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s11658-024-00622-5","volume":"29","author":"A Wang","year":"2024","unstructured":"Wang A, Zeng Y, Zhang W, Zhao J, Gao L, Li J, et al. N(6)-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing. Cell Mol Biol Lett. 2024;29:106.","journal-title":"Cell Mol Biol Lett"},{"key":"3917_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12964-023-01343-6","volume":"21","author":"L Gao","year":"2023","unstructured":"Gao L, Wang A, Chen Y, Cai X, Li Y, Zhao J, et al. FTO facilitates cancer metastasis by modifying the m(6)A level of FAP to induce integrin\/FAK signaling in non-small cell lung cancer. Cell Commun Signal. 2023;21:311.","journal-title":"Cell Commun Signal"},{"key":"3917_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper J, Giancotti FG. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell. 2019;35:347\u201367.","journal-title":"Cancer Cell"},{"key":"3917_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-biochem-032620-105728","volume":"91","author":"AM Pedley","year":"2022","unstructured":"Pedley AM, Pareek V, Benkovic SJ. The purinosome: a case study for a mammalian metabolon. Annu Rev Biochem. 2022;91:89\u2013106.","journal-title":"Annu Rev Biochem"},{"key":"3917_CR24","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1016\/j.molcel.2023.09.028","volume":"83","author":"MC Chou","year":"2023","unstructured":"Chou MC, Wang YH, Chen FY, Kung CY, Wu KP, Kuo JC, et al. PAICS ubiquitination recruits UBAP2 to trigger phase separation for purinosome assembly. Mol Cell. 2023;83:4123\u201340.e12.","journal-title":"Mol Cell"},{"key":"3917_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13046-022-02581-1","volume":"42","author":"Y Xu","year":"2023","unstructured":"Xu Y, Song M, Hong Z, Chen W, Zhang Q, Zhou J, et al. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer. J Exp Clin Cancer Res. 2023;42:10.","journal-title":"J Exp Clin Cancer Res."},{"key":"3917_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201724","volume":"10","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Ji M, Xia Y, Han X, Li M, Li W, et al. Silencing of IRF8 mediated by m6A modification promotes the progression of T-cell acute lymphoblastic leukemia. Adv Sci. 2023;10:e2201724.","journal-title":"Adv Sci"},{"key":"3917_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41419-024-06566-0","volume":"15","author":"L Ge","year":"2024","unstructured":"Ge L, Rui Y, Wang C, Wu Y, Wang H, Wang J. The RNA m(6)A reader IGF2BP3 regulates NFAT1\/IRF1 axis-mediated anti-tumor activity in gastric cancer. Cell Death Dis. 2024;15:192.","journal-title":"Cell Death Dis"},{"key":"3917_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-018-0172-9","volume":"51","author":"M Meng","year":"2018","unstructured":"Meng M, Chen Y, Jia J, Li L, Yang S. Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines. Biol Res. 2018;51:24.","journal-title":"Biol Res"},{"key":"3917_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41419-020-2708-5","volume":"11","author":"N Huang","year":"2020","unstructured":"Huang N, Xu C, Deng L, Li X, Bian Z, Zhang Y, et al. PAICS contributes to gastric carcinogenesis and participates in DNA damage response by interacting with histone deacetylase 1\/2. Cell Death Dis. 2020;11:507.","journal-title":"Cell Death Dis"},{"key":"3917_CR30","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1016\/j.cell.2024.05.011","volume":"187","author":"DH Tran","year":"2024","unstructured":"Tran DH, Kim D, Kesavan R, Brown H, Dey T, Soflaee MH, et al. De novo and salvage purine synthesis pathways across tissues and tumors. Cell. 2024;187:3602\u201318.e20.","journal-title":"Cell"},{"key":"3917_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.canlet.2019.11.013","volume":"470","author":"AD Robinson","year":"2020","unstructured":"Robinson AD, Eich ML, Varambally S. Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities. Cancer Lett. 2020;470:134\u201340.","journal-title":"Cancer Lett"},{"key":"3917_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.483","volume":"5","author":"Y Li","year":"2024","unstructured":"Li Y, Zhu L, Mao J, Zheng H, Hu Z, Yang S, et al. Genome-scale CRISPR-Cas9 screen identifies PAICS as a therapeutic target for EGFR wild-type non-small cell lung cancer. MedComm. 2024;5:e483.","journal-title":"MedComm"},{"key":"3917_CR33","doi-asserted-by":"publisher","first-page":"14258","DOI":"10.1021\/jacs.2c05072","volume":"144","author":"M Prejan\u00f2","year":"2022","unstructured":"Prejan\u00f2 M, \u0160kerlov\u00e1 J, Stenmark P, Himo F. Reaction mechanism of human PAICS elucidated by quantum chemical calculations. J Am Chem Soc. 2022;144:14258\u201368.","journal-title":"J Am Chem Soc"},{"key":"3917_CR34","doi-asserted-by":"publisher","first-page":"11656","DOI":"10.1074\/jbc.RA120.013695","volume":"295","author":"J \u0160kerlov\u00e1","year":"2020","unstructured":"\u0160kerlov\u00e1 J, Unterlass J, G\u00f6ttmann M, Marttila P, Homan E, Helleday T, et al. Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target. J Biol Chem. 2020;295:11656\u201368.","journal-title":"J Biol Chem"},{"key":"3917_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrc3792","volume":"14","author":"FJ Sulzmaier","year":"2014","unstructured":"Sulzmaier FJ, Jean C, Schlaepfer DD. FAK in cancer: mechanistic findings and clinical applications. Nat Rev Cancer. 2014;14:598\u2013610.","journal-title":"Nat Rev Cancer"},{"key":"3917_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1083\/jcb.201105103","volume":"195","author":"XY Li","year":"2011","unstructured":"Li XY, Zhou X, Rowe RG, Hu Y, Schlaepfer DD, Ili\u0107 D, et al. Snail1 controls epithelial-mesenchymal lineage commitment in focal adhesion kinase-null embryonic cells. J Cell Biol. 2011;195:729\u201338.","journal-title":"J Cell Biol"},{"key":"3917_CR37","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","volume":"75","author":"X Song","year":"2021","unstructured":"Song X, Xu H, Wang P, Wang J, Affo S, Wang H, et al. Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. J Hepatol. 2021;75:888\u201399.","journal-title":"J Hepatol"},{"key":"3917_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/gutjnl-2022-327927","volume":"73","author":"M Canel","year":"2023","unstructured":"Canel M, S\u0142awi\u0144ska AD, Lonergan DW, Kallor AA, Upstill-Goddard R, Davidson C, et al. FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. Gut. 2023;73:131\u201355.","journal-title":"Gut"},{"key":"3917_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00558-0","volume":"12","author":"X Tan","year":"2024","unstructured":"Tan X, Kong D, Tao Z, Cheng F, Zhang B, Wang Z, et al. Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling. Biomark Res. 2024;12:13.","journal-title":"Biomark Res"},{"key":"3917_CR40","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.jmb.2006.12.027","volume":"366","author":"SX Li","year":"2007","unstructured":"Li SX, Tong YP, Xie XC, Wang QH, Zhou HN, Han Y, et al. Octameric structure of the human bifunctional enzyme PAICS in purine biosynthesis. J Mol Biol. 2007;366:1603\u201314.","journal-title":"J Mol Biol"},{"key":"3917_CR41","first-page":"e3935","volume":"23","author":"R Chamani","year":"2025","unstructured":"Chamani R, Darvand Araghi MH. Introducing new inhibitors of PAICS, a de novo purine biosynthesis enzyme, through structure-based virtual screening. Iran J Biotechnol. 2025;23:e3935.","journal-title":"Iran J Biotechnol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03917-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03917-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03917-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:03:08Z","timestamp":1787608988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03917-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":41,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026,9,15]]}},"alternative-id":["3917"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03917-3","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The research involving human LUAD samples was approved by the First Affiliated Hospital of Soochow University (Approval No. 2022-276, dated March 1, 2022). All procedures related to human research were performed in compliance with institutional ethical guidelines. All animal experiments were independently approved by the Laboratory Animal Center of Soochow University School of Medicine (Approval No. 202501A0007, dated March 24, 2025). All in vivo vertebrate animal experiments were strictly conducted in accordance with national and institutional guidelines for the care and use of laboratory animals. All methodological procedures adopted in this human and animal study complied with the relevant official guidelines and regulatory requirements.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}